Drug Maker Sanofi-Aventis to procure Genzyme in support of $20B
Voguish U.S. premarket trading, Genzyme provide rose $1.22 to $75.52.Termeer willpower step down at the same time as chairman and boss of Genzyme following completion of the deal, but willpower keep a consulting role at the same time as co-chairman with Viehbacher of an integration steering board.